Study examines the comparative cardiovascular efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes.
Currently, ADHD diagnoses are mostly made through cognitive and behavioural observations. However, this can be complemented—or perhaps even replaced in the future—by computational neuroscience.